Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

v3.23.1
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2022
Asset Acquisition [Abstract]  
Schedule of purchase consideration
Equity consideration   $ 3,293,479  
Warrants issued as consideration     680,000  
Total purchase consideration   $ 3,973,479  

 
Schedule of assets and liabilities
Cash   $ 77,060  
Prepaid assets     49,380  
Fixed assets     19,551  
In-process research and development     2,900,000  
Accounts payable & accrued expenses     (335,423)  
Net assets acquired, excluding Goodwill     2,710,568  
Goodwill     1,262,911  

 
Schedule of asset acquisition
2,700,000 shares of Pasithea common stock   $ 3,402,000  
Warrants to acquire 1,000,000 shares of common stock at exercise price of $1.88     522,358  
Cash     1,000,000  
Non-refundable payment for AlloMek transaction expenses     50,000  
Pasithea transaction expenses     697,121  
Total cost of asset acquisition   $ 5,671,479